Daniel Simon

Daniel is passionate about helping get great science to patients. Having fallen in love with molecular biology at an early age, he learned he’d most enjoy being on the business side of life sciences, and has spent the last 20 years in industry working across pharmaceuticals, biotech and diagnostics.

Previously, Daniel was responsible for leading Guardant Health’s biopharma business development. Over 7+ years he built a team supporting more than 100 companies and 400 clinical trials using Guardant’s liquid biopsy platform to help accelerate drug development. Daniel started his career at McKinsey & Company in London, working in the Pharmaceutical and Medical Products group, leading client work in business strategy, innovation, BD and operations. Daniel has also served in business development, strategy, and market planning roles at MyoKardia, Onyx Pharmaceuticals, and Genentech.

Daniel holds an M.A. Hons. in Natural Sciences from the University of Cambridge and an M.B.A. from the University of Pennsylvania's Wharton School.